Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

By sjmartinez • May 26, 2023

Bhattacharya D, Aronsohn A, Price J, Lo Re V; AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. 2023 May 25:ciad319. doi: 10.1093/cid/ciad319. Epub ahead of print. PMID: 37229695.

Tags: Direct-acting antivirals, HCV guidance, HCV prevention, HCV screening, HCV treatment, Infectious Diseases, Publications

A novel risk-adjusted metric to compare hospitals on their antibiotic-prescribing at hospital discharge

Livorsi DJ, Merchant JA, Cho H, Goetz MB, Alexander B, Beck B, Goto M. A novel risk-adjusted metric to compare hospitals on their antibiotic-prescribing at[...]

Severe flea-borne typhus complicated by hemophagocytic lymphohistiocytosis: A case report and review of literature

Zamora Gonzalez RA, Mayo MS, Jeng AC. Severe flea-borne typhus complicated by hemophagocytic lymphohistiocytosis: A case report and review of literature. IDCases. 2024 Apr 15;36:e01955.[...]

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro[...]